INOGEN, INC. (NASDAQ:INGN) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k

8 years ago

INOGEN, INC. (NASDAQ:INGN) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders.

Inogen, Inc. (the Company) held its 2017 annual meeting of
stockholders on May 11, 2017 (the Annual Meeting).Of the
20,558,677 shares of the Companys common stock outstanding as of
the record date of March 17, 2017, 19,399,843 shares were
represented at the Annual Meeting, either in person or by proxy,
constituting approximately 94.36% of the outstanding shares of
common stock. The matters voted on at the Annual Meeting and the
votes cast with respect to each such matter are set forth below:

1.	Election of Class III Directors.The following nominees were elected to serve as Class III directors, to hold office until the Companys 2020 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified:

Nominee	Votes For		Votes Withheld	Broker Non-Votes
Heath Lukatch, Ph.D.	13,123,269	4,458,845	1,817,729
Raymond Huggenberger	12,951,502	4,630,612	1,817,729

2.	Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Deloitte Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017 was ratified based on the following results of voting:

Votes For		Votes Against		Abstentions		Broker Non-Votes
19,379,748	12,242	7,853	N/A

3.	Advisory Vote on Executive Compensation. The Companys stockholders advised that they were in favor of the named executive officers compensation as disclosed in the proxy statement. The votes regarding the proposal were as follows:

Votes For		Votes Against		Abstentions		Broker Non-Votes
17,147,676	418,437	16,001	1,817,729

4.	Advisory Vote on Frequency of Future Advisory Votes on Executive Compensation. The Companys stockholders advised that they were in favor of one year as the frequency of holding a non-binding advisory vote on named executive officers compensation. The votes regarding the proposal were as follows:

1 Year		2 Years		3 Years		Abstained		Broker Non-Votes
15,038,368	145,402	2,387,744	10,600	1,817,729

In accordance with the voting results for this proposal, the
board of directors of the Company has determined that the Company
will hold future stockholder advisory votes on the compensation
of the Companys named executive officers every year. The next
required advisory vote on the frequency of future stockholder
advisory votes on the compensation of the Companys named
executive officers will take place no later than at the Companys
2023 annual meeting of stockholders.

About INOGEN, INC. (NASDAQ:INGN)
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries. INOGEN, INC. (NASDAQ:INGN) Recent Trading Information
INOGEN, INC. (NASDAQ:INGN) closed its last trading session down -1.29 at 82.01 with 241,022 shares trading hands.